These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16314444)

  • 1. 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma.
    Khadzkou K; Buchwald P; Westin G; Dralle H; Akerström G; Hellman P
    J Histochem Cytochem; 2006 Mar; 54(3):355-61. PubMed ID: 16314444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.
    Yavropoulou MP; Panagiotou G; Topouridou K; Karayannopoulou G; Koletsa T; Zarampoukas T; Goropoulos A; Chatzaki E; Yovos JG; Pazaitou-Panayiotou K
    J Endocrinol Invest; 2017 Dec; 40(12):1327-1335. PubMed ID: 28589382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 25-Hydroxyvitamin D3 1alpha-hydroxylase expression in breast cancer and use of non-1alpha-hydroxylated vitamin D analogue.
    Segersten U; Holm PK; Björklund P; Hessman O; Nordgren H; Binderup L; Akerström G; Hellman P; Westin G
    Breast Cancer Res; 2005; 7(6):R980-6. PubMed ID: 16280049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D receptor expression is linked to potential markers of human thyroid papillary carcinoma.
    Izkhakov E; Somjen D; Sharon O; Knoll E; Aizic A; Fliss DM; Limor R; Stern N
    J Steroid Biochem Mol Biol; 2016 May; 159():26-30. PubMed ID: 26907966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D in thyroid tumorigenesis and development.
    Clinckspoor I; Verlinden L; Mathieu C; Bouillon R; Verstuyf A; Decallonne B
    Prog Histochem Cytochem; 2013 Aug; 48(2):65-98. PubMed ID: 23890557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sorafenib-sparing effect in the treatment of thyroid carcinoma cells attained by co-treatment with a novel isoflavone derivative and 1,25 dihydroxyvitamin D3.
    Izkhakov E; Sharon O; Knoll E; Aizic A; Fliss DM; Kohen F; Stern N; Somjen D
    J Steroid Biochem Mol Biol; 2018 Sep; 182():81-86. PubMed ID: 29702263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors.
    Clinckspoor I; Hauben E; Verlinden L; Van den Bruel A; Vanwalleghem L; Vander Poorten V; Delaere P; Mathieu C; Verstuyf A; Decallonne B
    J Histochem Cytochem; 2012 Jul; 60(7):502-11. PubMed ID: 22511602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
    Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
    Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse.
    Masuda S; Byford V; Arabian A; Sakai Y; Demay MB; St-Arnaud R; Jones G
    Endocrinology; 2005 Feb; 146(2):825-34. PubMed ID: 15498883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of cyclooxygenase 2 expression in papillary thyroid carcinoma.
    Lo CY; Lam KY; Leung PP; Luk JM
    Eur J Endocrinol; 2005 Apr; 152(4):545-50. PubMed ID: 15817909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
    Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
    Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis.
    Cerutti JM; Oler G; Michaluart P; Delcelo R; Beaty RM; Shoemaker J; Riggins GJ
    Cancer Res; 2007 Aug; 67(16):7885-92. PubMed ID: 17699795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.
    Blomberg Jensen M; Andersen CB; Nielsen JE; Bagi P; Jørgensen A; Juul A; Leffers H
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):376-82. PubMed ID: 20362668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
    Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
    Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D less-calcemic analog modulates the expression of estrogen receptors, vitamin D receptor and 1α-hydroxylase 25-hydroxy vitamin D in human thyroid cancer cell lines.
    Somjen D; Grafi-Cohen M; Posner GH; Sharon O; Kraiem Z; Stern N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():80-2. PubMed ID: 23059472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma.
    Penna-Martinez M; Ramos-Lopez E; Stern J; Hinsch N; Hansmann ML; Selkinski I; Grünwald F; Vorländer C; Wahl RA; Bechstein WO; Zeuzem S; Holzer K; Badenhoop K
    Thyroid; 2009 Jun; 19(6):623-8. PubMed ID: 19499989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics.
    Seubwai W; Wongkham C; Puapairoj A; Khuntikeo N; Wongkham S
    Cancer; 2007 Jun; 109(12):2497-505. PubMed ID: 17487855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells.
    Segersten U; Björklund P; Hellman P; Akerström G; Westin G
    Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
    Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R
    Thyroid; 2011 Mar; 21(3):267-77. PubMed ID: 21323588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor expression in invasive papillary thyroid carcinoma.
    de Araujo-Filho VJ; Alves VA; de Castro IV; Lourenço SV; Cernea CR; Brandão LG; Ferraz AR
    Thyroid; 2009 Nov; 19(11):1233-7. PubMed ID: 19888861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.